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Background: The purpose of this study was to gain an understanding of the profiles of the new 
treatment demands posed by opioid addicts between 2005 and 2010 at the addictive disorders 
assistance units in Galicia, Spain.
Methods: A cluster analysis was performed using data from 1,655 treatment entrants. Clusters 
were constructed using sociodemographic and medicolegal variables. A cluster analysis was 
also conducted according to age. Once clusters were defined, their association with the follow-
ing variables was analyzed: age at first use of opioids, years of use, frequency of opioid use in 
the previous month, psychiatric treatment, cocaine use, existence of a drug-dependent partner, 
and source of referral.
Results: Four clusters were obtained in the main analysis. Cluster 1 (34.01%) consisted of 
young males, cluster 2 (16.19%) consisted of not-so-young males, cluster 3 (32.62%) con-
sisted mainly of older males and a small group of females, and cluster 4 (17.18%) was made 
up entirely of women. With regard to age-related clusters, two clusters were obtained in those 
under the age of 30 years: cluster 1 (73%) without medicolegal complications and cluster 2 
(27%) with medicolegal complications. For those over the age of 30 years, two clusters were 
obtained: cluster 1 (53.92%) with hardly any medicolegal complications and cluster 2 (46.08%) 
with medicolegal complications.
Conclusion: Cluster analysis suggests that there have been no substantial changes in variables 
indicating greater severity in this new group of patients. Women are likely to seek help earlier, 
which reduces their duration of opioid use. The younger the patient, the shorter the duration of 
opioid use and the greater the likelihood of cessation of intravenous use. Public health systems 
should use a two-pronged treatment strategy of short but intense cessation therapies for women 
and younger treatment entrants and longer maintenance and replacement therapies for older 
treatment entrants with more psychosocial and medical complications.
Keywords: opioid dependence, cluster analysis, treatment-seeking, sex, age
Introduction
Addiction to opioids is a chronic condition with severe repercussions in the health 
domain (early death, transmission of infectious diseases) and psychosocial domain 
(legal, family, social, and occupational problems).1,2
This serious public health issue has gone through different stages in Europe, includ-
ing Spain in general and Galicia specifically, ie, the northwestern region of Spain 
where our study took place,3 from being a serious social and public health problem 
(particularly with regard to transmission of human immunodeficiency virus [HIV] and 
hepatitis C virus [HCV]) in the 1980s and 1990s, to later becoming a less prominent 
problem,3 although a recent meta-analysis4 places opioid dependency as the second 
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leading mental disorder with the greatest risk of death behind 
only puerperal psychiatric disorder.
In Spain, according to data from a general survey of the 
adult population conducted in 1995, 0.8% had tried heroin 
and 0.5% had done so in the previous 12 months, while in 
2011 the corresponding figures were 0.6% and 0.1%.5 This 
decrease is reflected in the clinical setting, with a reduction in 
admissions for treatment of opioid abuse of 93.1% in 1995 to 
36.9% in 2011 (over the total of substance abuse admissions) 
at the specialized units in Galicia, with no changes in the 
treatment system during that period.6 This decrease has also 
been reported in the European Union,3 which has experienced 
a decrease from 59,000 in 2007 to 31,000 in 2012. The same 
report indicates that, in Spain, the prevalence of problem 
opioid use was less than 2.5 per 1,000 in 2011.3
Of particular interest is whether these changes are a mere 
reduction in numbers or whether there have been changes in 
the profile of patients seeking treatment in more recent years. 
Recently, profile analyses have been conducted regarding the 
use of tobacco,7,8 alcohol,9 and cocaine,10 but there has been 
less research concentrating on heroin users. There is indeed 
evidence of a high prevalence of dual disorders in opioid 
users.11,12 For instance, the COPSIAD study,13 also conducted 
in Galicia, reported a high prevalence of personality disorders 
(26.5%), mood disorders (20.6%), anxiety disorders (11.9%), 
and psychotic disorders (7.6%) in 805 persons who sought 
treatment for heroin use at specialized units.
The following variables have been identified to have 
an influence on the level of disability in opioid-addicted 
patients: age, with a greater probability of polyconsump-
tion of addictive substances amongst younger populations;14 
sex, with females showing a lower incidence of opioid 
addiction, more psychiatric disorders,15 more chronic health 
problems, and lower levels of social and occupational 
functioning,16 their partners having a greater influence on 
initiation of use, and females also more frequently practicing 
prostitution and sharing injecting paraphernalia;17 psychiatric 
comorbidity, with figures ranging between 44% and 93% 
of persons seeking treatment;12,18 infectious diseases, with a 
25-year longitudinal clinical study conducted in Spain report-
ing that 47.2% of a sample was also diagnosed with HIV and 
81.1% with hepatitis B/HCV;18,19 and legal problems, which 
are associated with greater severity of addiction, and, in some 
clinical samples, even survival at 12 months.19,20
These variables determine a variety of user profiles 
that have an influence on preventive and therapeutic deci-
sion making.21,22 For instance, patients with less severe 
profiles (fewer physical and psychiatric comorbidities, less 
polysubstance abuse, fewer incarcerations) will benefit from 
shorter programs while those with more severe profiles will 
benefit from long-term maintenance programs.23 Females 
would require more exhaustive assessment because they have 
a higher risk of a more severe profile and, as a result, may 
need more intensive and individualized treatments.24
The aim of this study was to gain an understanding of the 
profile of those who started treatment for opioid addiction 
for the first time between 2005 and 2010 at the addictive 
disorders assistance units in Galicia. Our a priori hypothesis 
was that variables with historically defined severity profiles 
will continue to exist for new treatment entrants.
Materials and methods
This was a cross-sectional and descriptive study of opioid-
dependent patients starting treatment at the addictive disor-
ders assistance units of Galicia in the northwestern region 
of Spain, which has a population of 2,797,653. The service 
comprises 17 drug dependency units and six alcoholism units, 
as part of the assistance provided by the free public health 
system. The service offers opioid substitution and drug-free 
treatment in inpatient and outpatient settings, all of which 
offer psychosocial rehabilitation.
sample
The study included all patients who started treatment for 
the first time in their lives between 2005 and 2010 and who 
had an opioid as their main substance of abuse (n=1,800). 
Of these, 145 were excluded because they could not provide 
data for any of the variables selected for the study. Therefore, 
the final sample consisted of 1,655 patients.
Procedure
In Galicia, health care assistance has been registered since 
1994 using a specific computer application of the Galician 
Health Service. This tool, based on the EuropASI,25 collects 
patient details as necessary to be able to provide health care 
services at each unit. Sociodemographic, clinical, treatment, 
legal, and abuse (main and secondary substances) variables 
are collected, as well as data on infectious diseases (in par-
ticular hepatitis and HIV).
The data collected on admission for treatment are sent 
to the Spanish Department for the National Plan on Drugs 
(Ministry of Health and Social Policy, Government of Spain) 
and are included on the treatment admission register for use 
of psychoactive substances.
The procedure used to obtain information in this study 
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First-time admissions for opioid treatment
following inclusion criteria: admission for treatment at any 
assistance unit in Galicia between 2005 and 2010 and an 
opioid being the main substance of abuse. Our definition 
of main substance of abuse was a substance that met the 
following conditions: the most frequently used, the one 
leading to treatment demand, and the one causing greatest 
disability. Eligibility criteria were: ability to understand and 
sign informed consent to start treatment; age 18–65 years; 
and a Diagnostic and Statistical Manual of Mental Disorders 
(DSM) diagnosis of opioid dependence, ie, an opioid being 
the main substance of abuse.
ethics statement
This study was approved by the ethics committee for 
clinical research in Galicia (2014-117). All the research 
was conducted according to the principles expressed in the 
Declaration of Helsinki. Participants provided their written 
informed consent to have their medical data used for research 
in all cases. Research was not conducted outside of country 
of residence.
statistical analysis
An important decision in performing a cluster analysis is 
the selection of a set of measures that will serve as the basis 
for the cluster.
analysis
A public health investigative approach was chosen for 
selection of clustering variables that could reveal the het-
erogeneity of new opioid users.26 The choice was balanced 
between variables that have shown prognostic importance 
and variables that can be ascertained rapidly and reliably in 
a valid manner. Sociodemographic variables included sex, 
age, marital status (single/married/other), education (primary 
school/beyond primary school), and source of income 
(job/other). With regard to drug use variables, the variable 
parenteral route of administration was selected (yes/no). 
HIV/acquired immune deficiency syndrome (AIDS) (yes/no) 
and HCV (yes/no) status was confirmed by self-report and 
clinical data, and incarceration was the variable considered 
from a legal standpoint (yes/no).12,14–20
clustering technique
Subtypes of opioid users who started treatment for the first 
time were identified by a cluster analysis in two phases using 
the Statistical Package for the Social Sciences for Windows 
version 19 software (IBM Corporation, Armonk, NY, USA). 
This statistical technique is an exploratory procedure for 
identifying natural groups in a set of data (categorical and con-
tinuous) that would not be possible to detect otherwise. The 
first stage in the two-step clustering involves assigning cases 
to “preclusters”. In the second step, the preclusters are clus-
tered using the hierarchical clustering algorithm. All analyses 
were performed using measurement of log-similarity (such as 
that required by analyses including continuous variables as 
well as categories). We used the Bayesian information crite-
rion fit statistic to evaluate each solution’s fit relative to the 
other cluster solution. For the Bayesian information criterion, 
smaller values suggest better fitting solutions.27,28
Once the clusters were obtained, they were compared 
on the basis of the following clinically relevant variables: 
three variables related to opioid use, ie, age at initiation of 
opioid use, years of use, and frequency of opioid use over the 
past month (daily/other); a further three variables related to 
comorbidity, ie, psychiatric treatment (yes/no), cocaine use 
(yes/no), and existence of a drug-addicted partner (yes/no); 
and the last one related to motivation for treatment and source 
of referral (health services/own initiative/other).
We used the Student’s t-test and analysis of variance with 
Bonferroni correction to examine the differences between 
clusters in age at initiation of heroin use. Chi-square analyses 
with Bonferroni correction were carried out for the remain-
ing variables. Differences were considered to be statistically 
significant at P,0.05 (P,0.025 for the chi-square test with 
Bonferroni correction for two-level categorical variables and 
P,0.015 for three-level categorical variables).
Results
The mean age of the sample was 33.29±8.3 years, 81.8% 
were male, 71.9% were single, and 58.5% had more than 
primary education. All baseline variables from the whole 
group are shown in Table 1.
cluster analysis
Of the 1,655 study participants, 563 were classified in the 
first group (cluster 1), 268 in the second group (cluster 2), 
540 in the third group (cluster 3), and 284 in the fourth group 
(cluster 4), as shown in Table 2.
With regard to demographic variables, subjects in clusters 
1 and 4 were the youngest while those in cluster 2 had a higher 
mean age (F
(3,1651) 
=90.64, P,0.001). Clusters 1 and 2 were 
composed entirely of males and cluster 4 entirely of females 
(χ2
(1)
=1,544.34, P,0.001). All subjects in cluster 1 were 
single, none in cluster 2 were single, while in clusters 3 and 4 
they were more likely to be single (χ2
(1) 
=925.63, P,0.001). 
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Table 1 All baseline variables from the final sample
Baseline variables M (SD)















intravenous use (yes) 258 (15.6)
hiV/aiDs (yes) 123 (7.4)
hepatitis c (yes) 329 (19.9)
incarceration (yes) 446 (26.9)
M (SD)
age of initiation of use, years 22.5 (7.5)
Years of use 10.9 (9.1)
n (%)
Psychiatric treatment (yes) 402 (24.3)
cocaine use (yes) 829 (50.1)
Drug-dependent partner (yes) 324 (19.6)
source of referral
health services 315 (19.0)
Own initiative 729 (44.0)
Other 611 (36.9)
Frequency of use in the last month (daily) 1,152 (69.6)
Abbreviations: AIDS, acquired immune deficiency syndrome; HIV, human immuno­
deficiency virus; M, mean; SD, standard deviation.
primary education, while clusters 2 and 3 were more likely to 
have primary education only (χ2
(1) 
=36.12, P,0.001). Subjects 
in clusters 1 and 2 were more likely to derive their income from 
work, while those in clusters 3 and 4 were more likely to earn 
income from other sources (χ2
(1) 
=87.78, P,0.001).
With regard to method of drug administration, none 
of the subjects in clusters 1 and 2 had used the parenteral 
route, while those in cluster 3 were more likely to have used 
this route (χ2
(1) 
=431.41, P,0.001). A higher proportion of 
subjects in cluster 3 were diagnosed with HIV/AIDS (χ2
(1) 
= 
226.38, P,0.001) and HCV (χ2
(1) 
=648.72, P,0.001) than 
in cluster 4, with none in clusters 1 and 2 having these dis-
eases. None of the subjects in cluster 1 had been incarcerated, 




relationship between the four clusters 
and other use-related variables
Having defined the clusters, we analyzed their association 
with the following variables: age of initiation of opioid use, 
years of opioid use, frequency of opioid use in the previous 
month, psychiatric treatment, cocaine use, existence of a 
drug-addicted partner, and source of referral (Table 3).
Subjects in cluster 3 started to use opioids at a younger age, 
followed by clusters 1 and 4, and, lastly, those with the oldest 
age of initiation were in cluster 2 (F
(3,1651) 
=43.23, P,0.001). 
Subjects in cluster 3 had been using opioids for longest, fol-
lowed by subjects in cluster 2 and then cluster 1; those who 
had been using for the least number of years were women in 
cluster 4 (F
(3,1651) 
=110.28, P,0.001). Subjects in cluster 4 were 
more likely to have received psychiatric treatment than those in 
cluster 2 (χ2
(1)
 =36.46, P,0.001). Subjects in cluster 2 were less 
likely to have used cocaine (χ2
(1) 
=18.11, P,0.001) and those in 
cluster 4 were more likely to have a drug-addicted partner (χ2
(1) 
= 
80.31, P,0.001). Subjects in cluster 3 were more likely than 
those in clusters 1 and 2 to have been referred from a health unit 
and less likely than those in clusters 1 and 2 to have sought treat-
ment on their own initiative (χ2
(1) 
=18.68, P,0.01). Subjects in 
cluster 3 were the least likely to have used opioids on a daily 




Given the existing age differences, two further cluster analyses 
were performed. The first comprised subjects under the age 
of 30 years and the second comprised those aged 30 years or 
over. Of the 648 study participants younger than 30 years, 473 
were classified in the first group (cluster 1) and 175 were clas-
sified in the second group (cluster 2), as shown in Table 4.
Females (χ2
(1)
 =10.04, P,0.01), those who had gone 
beyond primary schooling (χ2
(1)
 =36.12, P,0.001), and 
those whose income was derived from work (χ2
(1)
 =19.5, 
P,0.001) were more likely to be included in cluster 1. 
None of the subjects in cluster 1 had used the parenteral 
route of opioid administration (χ2
(1)
 =236.18, P,0001), been 
diagnosed with HIV/AIDS (χ2
(1)
 =33.04, P,0.001) or HCV 
(χ2
(1)




After defining the clusters in the sample of those under 
the age of 30 years, we analyzed their relationship with the 
same variables we used in the overall sample (Table 5). 
Subjects in cluster 2 were younger when they started using 
opioids than those in cluster 1 (t
(646)
 =6.03, P,0.001), had 
been using for longer (t
(646)
 =-6.76, P,0.001), were more 
likely to have used cocaine (χ2
(1) 
=6.76, P,0.001), and were 




Of the 1,007 study participants aged 30 years or older, 
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age, years (sD) 30.3 (7) 37.7 (8.2) 35.7 (7.9) 30.2 (8.1) 90.64***,a
sex, %
Male 100 100 96.9 0 1,544.34***,b
Female 0 0 3.1 100
Marital status, %
single 100 0 78.1 72.2 925.63***,c
Married 0 52.2 9.3 11.6
Other 0 47.8 12.6 16.2
education, %
Primary 37.1 46.6 49.4 30.3 36.12***,d
Beyond primary 62.9 53.4 50.6 69.7
source of income, %
Job 49.4 52.6 27.8 28.5 87.78***,e
Other 50.6 47.4 72.2 71.5
intravenous use, % 0 0 41.5 12 431.41***,f
hiV/aiDs, % 0 0 21.3 2.8 226.38***,g
hcV, % 0 0 55.4 10.6 648.72***,h
incarceration, % 0 25.4 65.4 8.8 660.46***,i
Notes: ***P,0.001. aBonferroni correction, significant differences between clusters 1 and 2, 1 and 3, 2 and 3, 2 and 4, 3 and 4; bBonferroni correction, significant differences 
between clusters 1 and 3, 1 and 4, 2 and 3, 2 and 4, 3 and 4; cBonferroni correction, significant differences between clusters 1 and 2, 1 and 3, 1 and 4, 2 and 3, 2 and 4, 
3 and 4; dBonferroni correction, significant differences between clusters 1 and 2, 1 and 3, 2 and 4, 3 and 4; eBonferroni correction, significant differences between clusters 
1 and 3, 1 and 4, 2 and 3, 2 and 4; fBonferroni correction, significant differences between clusters 1 and 3, 1 and 4, 2 and 3, 2 and 4, 3 and 4; gBonferroni correction, significant 
differences between clusters 1 and 3, 1 and 4, 2 and 3, 2 and 4, 3 and 4; hBonferroni correction, significant differences between clusters 1 and 3, 1 and 4, 2 and 3, 2 and 4, 
3 and 4; iBonferroni correction, significant differences between clusters 1 and 2, 1 and 3, 1 and 4, 2 and 3, 2 and 4, 3 and 4.
Abbreviations: AIDS, acquired immune deficiency syndrome; HCV, hepatitis C virus; HIV, human immunodeficiency virus; SD, standard deviation.
classified in the second group (cluster 2) (Table 6). Those 
who had completed education beyond primary school (χ2
(1)
 = 
30.66, P,0.001) and those whose source of income was 
from work (χ2
(1)
 =138.17, P,0.001) were in cluster 1. None 
of the subjects in cluster 1 had used the parenteral route of 
administration (χ2
(1)
 =258.23, P,0.001) or been diagnosed 
with HIV/AIDS (χ2
(1)
 =145.99, P,0.001). They were less 
likely to have contracted HCV (χ2
(1)
 =197.15, P,0.001), and 
none had been incarcerated (χ2
(1)
 =619.57, P,0.001).
Having defined the clusters in the sample for those aged 
30 years or older, we then analyzed their relationship with 
the same variables used for the overall sample (Table 7). 
Subjects in cluster 1 were older at age of initiation of use 
than those in cluster 2 (t
(1005) 
=6.16, P,0.001), had been 
using for fewer years (t
(1005) 
=-9.82, P,0.001), were less 
likely to have received psychiatric treatment (χ2
(1)
 =5, 
P,0.01), were more likely to have sought treatment on 
their own initiative (χ2
(1)
 =21.89, P,0.001), and were more 










age at initiation of use, years (sD) 22.2 (6.4) 26.1 (9.3) 20.2 (6.8) 24 (7.4) 43.23***,a
Years of use (sD) 8.2 (8) 11.5 (8.5) 15.7 (9.4) 6.2 (6.1) 110.28***,a
Psychiatric treatment (yes) 19.0% 17.5% 27.4% 35.2% 36.46***,b
cocaine use (yes) 53.6% 38.8% 50.0% 53.9% 18.11***,c
Drug-dependent partner (yes) 21.5% 33.8% 26.3% 53.9% 80.31***,d
source of referral
health services 16.2% 17.9% 21.9% 20.4% 18.68**,e
Own initiative 46.5% 51.9% 38.1% 43%
Other 37.3% 30.2% 40% 36.6%
Frequency of daily use in previous month 77.8% 73.9% 58% 71.5% 55.24***,f
Notes: **P,0.01; ***P,0.001. aBonferroni correction, significant differences between clusters 1 and 2, 1 and 3, 1 and 4, 2 and 3, 2 and 4, 3 and 4; bBonferroni correction, 
significant differences between clusters 1 and 3, 1 and 4, 2 and 3, 2 and 4, 3 and 4; cBonferroni correction, significant differences between clusters 1 and 2, 2 and 3, 2 and 4; 
dBonferroni correction, significant differences between clusters 1 and 4, 2 and 4, 3 and 4; eBonferroni correction, significant differences between clusters 1 and 3, 2 and 3; 
fBonferroni correction, significant differences between clusters 1 and 3, 1 and 4, 2 and 3, 3 and 4.
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This analysis yielded four clusters of opioid users seek-
ing treatment for the first time, consistent with the initial 
hypothesis. Earlier age of initiation and more years of use 
correlated with a greater likelihood of incarceration, more 
use of the parenteral route of administration, and therefore a 
greater likelihood of HIV and HCV infection.
What conclusions can we draw from the analysis of 
these clusters in relation to the variables discussed in the 
introduction?
age
The initial cluster analysis did not yield any conclusive 
results. The cluster containing the youngest male patients, 
ie, cluster 1, had the least clinically and socially severe 
characteristics, but the mean age in the female cluster was 
slightly younger and this cluster showed the greater severity. 
On the other hand, cluster 3 was worst clinically, but subjects 
in this cluster had a lower mean age than those in cluster 2, 
which was of intermediate severity. Undoubtedly, lower age 
at initiation of use is associated with lower mean age. This is 
clearly seen in the male clusters, where a more precocious age 
at initiation resulted in a longer duration of use and increased 
severity of addiction. In contrast with another study,16 we did 
not find a significant delay in age at initiation in our youngest 
patients. In the case of the female cluster, ie, cluster 4, this 
did not apply, suggesting that women tend to seek treatment 
earlier than men. Subanalysis of clusters aged younger versus 
older than 30 years identified two clusters in the under-30 
patients, firstly a cluster (73%) with no history of parenteral 
drug use, HCV/HIV infection, or prison stays, and secondly 
another cluster, in which 56.6% had been incarcerated, 44% 
had used the parenteral route of administration, 39.4% were 
HCV-positive, and 6.9% were HIV-positive. This cluster 
was characterized by greater addiction severity, despite its 
profile being better than that for subjects aged 30 years or 
older. In the 30 years or older clusters we see that 53.9% 
fell into a cluster in which 0% had been incarcerated, 0% 
used the parenteral route of administration, and 0% were 
HIV-positive, with 7.9% being HCV-positive, compared 
with 46.1% that came under another cluster in which 56.6% 
had been incarcerated, 39% had used the parenteral route of 
administration, 46.8% were HCV-positive, and 23.9% were 
HIV-positive. Women were more represented in the cluster 







Male 71.9 84 10.04**
Female 28.1 16
Marital status, %




Primary 37.1 46.6 36.12***
Beyond primary 62.9 53.4
source of income, %
Job 39.7 21.1 19.5***
Other 60.3 78.9
intravenous use, % 0 44 236.18***
hiV/aiDs, % 0 6.9 33.04***
hcV, % 0 39.4 208.72***
incarceration, % 0 56.6 660.46***
Notes: **P,0.01; ***P,0.001.
Abbreviations: AIDS, acquired immune deficiency syndrome; HCV, hepatitis C virus; 
HIV, human immunodeficiency virus.






age at initiation of use, years (sD) 20.14 (4.58) 17.75 (4.13) 6.03***
Years of use (sD) 4.78 (5.94) 8.13 (4.53) -6.76***
Psychiatric treatment (yes) 22.6% 26.3% 0.95
Use of cocaine (yes) 54.3% 65.7% 6.76**
Drug-dependent partner (yes) 25.2% 20% 1.87
source of referral
health services 14.4% 17.1% 1.24
Own initiative 40.8% 42.3%
Other 44.8% 40.6%
Frequency of use in previous month (daily) 78.9% 69.1% 6.65**
Notes: **P,0.01; ***P,0.001.
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First-time admissions for opioid treatment
of patients under 30 years of age and had less clinically 
severe addiction.
sex
As previously shown, women, with a lower incidence for this 
disorder made up an intermediate severity group. It appeared 
that the women in our study sought treatment earlier and on 
their own initiative, were more likely to undergo psychiatric 
treatment, and were more likely to have a drug-addicted 
partner. Our results are very similar to those reported 
elsewhere.3,29 Rates of opioid use, history of incarceration, 
and HIV/HVC status were lower in the female cluster than 
in the males making up cluster 3 (the most severe group), 
but were significantly higher in relation to the other male 
clusters, except for incarceration, rates of which were higher 
in cluster 2. These data reinforce this intermediate status. 
It should be noted that the small number of females included 
in cluster 3 had a high rate of HIV and HCV infection, 
were more likely to have a drug-addicted partner, were 
less likely to be single, and had a briefer history of daily 
use of opioids prior to the start of treatment than males in 
the same cluster.
The results of our study indicate that women in cluster 4 
sought treatment earlier, which would prevent the deteriora-
tion seen in the small group in cluster 3, and this pattern has 
been reported elsewhere.30,31
Psychiatric comorbidity
A previous history of psychiatric treatment was considered an 
indicator of psychiatric comorbidity, and was clearly higher 
in females; this was also common in males in cluster 3, ie, 
those with the most clinically severe opioid addiction. This 
would indirectly confirm an increased presence of psychiatric 
disorders in the most severe cases in both males and females, 
as other studies that have analyzed female samples in the 
same time frame have reported.30–32
infectious comorbidity
The more frequent the use of the parenteral route of admin-
istration, the higher the likelihood of contracting HIV and/or 
HCV infection. These three variables are decisive for cluster 
formation, with greater presence in that of greatest clinical 
severity, cluster 3.
legal problems
In terms of having a history of legal problems, the results are 
conclusive. Incarceration correlated with years of drug use, 
this being a clear indicator of addiction severity.







Male 84.9% 87.5% 1.41
Female 15.1% 12.5%
Marital status




Primary 32.6% 49.8% 30.66***
Beyond primary 67.4% 50.2%
source of income
Job 59.1% 22.4% 138.17***
Other 40.9% 77.6%
intravenous use 0% 39% 258.23***
hiV/aiDs 0% 23.9% 145.99***
hcV 7.9% 46.8% 197.15***
incarceration 0% 56.6% 619.57***
Note: ***P,0.001.
Abbreviations: AIDS, acquired immune deficiency syndrome; HCV, hepatitis C virus; 
HIV, human immunodeficiency virus.
Table 7 relationship between typologies of users aged 30 years or over and other variables associated with opioid addiction (n=1,007)
Variables Cluster 1  
n=543
Cluster 2  
n=464
t/χ2
age at initiation of use, years (sD) 25.9 (8.1) 22.7 (8.3) 6.16***
Years of use (sD) 11.7 (8.1) 17.2 (9.6) -9.82***
Psychiatric treatment (yes) 21.9% 28% 5**
cocaine use (yes) 44.6% 46.3% 0.31
Drug-dependent partner (yes) 16.6% 17.2% 0.07
source of referral
health services 18.8% 24.8% 21.89***
Own initiative 52.7% 37.9%
Other 28.5% 37.3%
Frequency of daily use in the last month 74.2% 55% 40.98***
Notes: **P,0.01; ***P,0.00.
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There has been an increase in the mean age of marriage in 
Galicia, which makes interpretation of this variable dif-
ficult. According to the Spanish Institute for Statistics,33 of 
the total number of marriages recorded in 2013 in Galicia, 
only 17.96% involved males under 30 years of age, whereas 
this figure increased by 30% in females. It is therefore not 
surprising that singles predominated in our youngest clusters, 
ie, clusters 1 and 4. It is indeed relevant that the most severe 
cluster, ie, cluster 3, contained a greater proportion of singles 
when compared with cluster 2, which had a similar mean age. 
This finding could indicate a protective factor in this group, 
or might indicate milder evolution of addiction.
source of income
As with marital status, there were more active workers in 
cluster 2 than in cluster 3, which is significant and might indi-
cate a protective factor or milder evolution of addiction.
education
A higher level of education seemed to correlate more with 
age than with severity of addiction.
cocaine use
Use of cocaine in this study was taken as an indicator of poly-
substance abuse. Use of cocaine was high in every cluster, 
reflecting a high prevalence of cocaine use among current 
heroin users, as reported in the COPSIAD study,13 where 
43.1% of users who reported heroin as their main substance 
of abuse also used cocaine. These figures are similar to those 
in the clusters in our study, with the exception of the lower 
figures in cluster 2, which contained more chronic users, who 
were likely to have started using heroin following a more 
classical, single-substance pattern.
having a drug-dependent partner
The likelihood of having a drug-dependent partner was par-
ticularly high in the female cluster, which might indicate a 
more partner-related start and continuation of opioid use.
Frequency of daily opioid use in 
the previous 30 days
The high number of subjects who reported using opioids 
daily in the previous month is to be expected, given that 
these patients were seeking treatment for the first time. Of 
particular interest is the fact the cluster with the greatest 
addiction severity showed the lowest rate of daily opioid 
use. This could be a consequence of lower socioeconomic 
status or might reflect a better knowledge of alternative 
substances available on the black market (methadone and 
other morphine derivatives or benzodiazepines) that can 
circumvent the need for daily use of opioids. Alternatively, 
it might indicate a tendency for opioid use to be minimized in 
this group. Another explanation is that this early abstinence 
is related to higher motivation to start treatment.34
study limitations
The main limitation of this study is that the study sample 
was collected from different units. While there were com-
mon action and collection protocols, and all units were 
trained in data collection procedures, our data did not have 
interexaminer reliability. This clinical scenario could have 
a greater effect on variables that are neither dichotomous 
nor biological. This group of patients were contacting the 
Galician addictive disorder treatment network for the first 
time, but whether they had had previous contact with other 
public facilities (correctional centers, other Spanish health 
services) or private services is unknown. This problem has 
been reported in other epidemiological studies.29 Subjects in 
our study were opioid addicts, and the validity of the data 
collected has to be considered in light of this fact; nonethe-
less, this is an important consideration in all studies of this 
type.35,36
However, despite these limitations, this is an extensive 
group of patients that reflects the real evolution of the demand 
for treatment resulting from opioid use. Our cluster analysis 
suggests that duration of use, parenteral drug use with the 
resulting risk of HIV/HCV infection, incarceration, lack 
of remunerated employment, a history of psychiatric treat-
ment, and being single are associated with greater addiction 
severity. Women appear to seek help earlier, which reduces 
their duration of use and improves the initial prognosis. The 
younger the patient, the briefer the duration of use, the less 
the likelihood of parenteral drug use, and hence the better 
the outlook.
Conclusion
In summary, analysis of clusters in patients seeking treat-
ment for opioid dependency for the first time at the Galician 
addictive disorder treatment network has given us the 
opportunity to gain an understanding of their characteristics 
and typologies, so that interventions can be adapted for this 
group. Patients presenting with characteristics indicating 
more severe addiction will require longer maintenance and 
replacement psychopharmacological treatment, as well as and 
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First-time admissions for opioid treatment
Patients not presenting with these characteristics could ben-
efit from shorter interventions focused on detoxification/
cessation and occupational recovery.
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